A noncontrolled trial of anti-TNF-alpha chimeric monoclonal antibody (infliximab, Remicade (R)) in exudative age-related macular degeneration

P.M. van Hagen, Goitzen Baarsma, CE van Bilsen, Robert Kuijpers, Jan van Laar, M (Martin) van der Ent, Paul van Daele, NJ Veeger, Hans Vingerling, TO Missotten

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)e691-e692
JournalActa Ophthalmologica
Volume92
Issue number8
DOIs
Publication statusPublished - 2014

Research programs

  • EMC OR-01-60-01

Cite this